Two Northwestern Medicine scientists have received NIH Director’s Awards, which fund innovative research with high-impact potential.
Patients with melanoma that has spread to the sentinel nodes did not see any survival benefit after a surgical procedure called immediate completion lymph node dissection, according to a study in the New England Journal of Medicine.
Consumer complaints for cosmetic products have more than doubled, but consumers may remain at risk because the industry receives little regulatory scrutiny, according to new research.
A new study has demonstrated how a specific class of immune cells represent a previously unknown link between high cholesterol and the development of symptoms characteristic of psoriasis.
Northwestern Medicine scientists showed how a microRNA family regulates aspects of autophagy and macropinocytosis in the stem cell–enriched limbal epithelium of the eye.
A Northwestern research team has developed a first-of-its-kind flexible microfluidic device that adheres to the skin and measures the wearer’s sweat.
Nearly 40 percent of patients with atopic dermatitis saw their disease completely or almost completely cleared with a new drug called dupilumab, according to a Northwestern Medicine clinical trial.
Kathleen Green, PhD, Joseph L. Mayberry, Sr., Professor of Pathology and Toxicology and professor of Dermatology, has been elected to the German National Academy of Sciences for her scientific achievements.
Forty percent of top-selling sunscreens don’t meet national standards for protection, and consumers are spending up to 3,000 percent more for products that provide equivalent benefit, according to new research.
Northwestern Medicine scientists have shown that a molecule called tenascin-C drives the excess scar buildup seen in fibrotic diseases.